|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/50 | |
| G01N 33/574 |
| (11) | Patento numeris | 2867671 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13736723.1 |
| Europos patento paraiškos padavimo data | 2013-06-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/048510 |
| Data | 2013-06-28 |
| (87) | Numeris | WO 2014/004990 |
| Data | 2014-01-03 |
| (30) | Numeris | Data | Šalis |
| 201261666703 P | 2012-06-29 | US | |
| 201261696752 P | 2012-09-04 | US |
| (72) |
SCHAFER, Peter, H., US
CHOPRA, Rajesh, GB
CORRAL, Laura, US
WANG, Maria, Yinglin, US
JACKSON, Pilgrim, US
LOPEZ-GIRONA, Antonia, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS |
| METHODS FOR DETERMINING DRUG EFFICACY USING CEREBLON-ASSOCIATED PROTEINS |